Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 02/03/2026 | Q4 | $8.1B | -- | -- | $0.75 | -- |
| 10/31/2025 | Q3 | $7.8B | $13.2B | $0.94 | $0.96 | -$0.03 |
| 07/30/2025 | Q2 | $8B | $13.3B | $1.00 | $0.94 | $0.06 |
| 05/06/2025 | Q1 | $7.6B | $12.7B | $0.93 | -- | -- |
| 02/04/2025 | Q4 | $6.8B | $12.7B | $0.54 | $0.62 | -$0.08 |
| 11/11/2024 | Q3 | $7.1B | $14.5B | $0.87 | $0.82 | $0.05 |
| 08/12/2024 | Q2 | $7.2B | $13.7B | $0.87 | $0.83 | $0.04 |
| 05/13/2024 | Q1 | $7.1B | $14.6B | $0.79 | $0.81 | -$0.02 |
| 02/06/2024 | Q4 | $6.9B | $14.4B | $0.57 | $0.56 | $0.00 |
| 11/13/2023 | Q3 | $6.7B | $13.5B | $0.64 | $0.61 | $0.03 |
| 08/11/2023 | Q2 | -- | $6.9B | $0.76 | -- | -- |
| 05/12/2023 | Q1 | -- | $17.2B | $0.64 | -- | -- |
| 02/03/2023 | Q4 | -- | $9.2B | $0.34 | -- | -- |
| 09/30/2022 | Q3 | -- | $9.1B | $0.30 | -- | -- |
| 08/10/2022 | Q2 | -- | $6.4B | $0.43 | -- | -- |
| 05/12/2022 | Q1 | -- | $12.2B | $0.34 | -- | -- |
| 02/04/2022 | Q4 | -- | $11.9B | $0.06 | -- | -- |
| 11/11/2021 | Q3 | -- | $11.7B | $0.36 | -- | -- |
| 08/04/2021 | Q2 | -- | $12.2B | $0.56 | -- | -- |
| 05/05/2021 | Q1 | -- | $12B | $0.57 | -- | -- |
| 03/23/2021 | Q4 | -- | $6B | -$0.26 | -- | -- |
| 11/04/2020 | Q3 | -- | $5.5B | $1.39 | -- | -- |
| 08/12/2020 | Q2 | -- | $5.2B | $0.54 | -- | -- |
| 05/12/2020 | Q1 | -- | $5.8B | $0.44 | -- | -- |
| 03/20/2020 | Q4 | -- | $10.1B | $0.33 | -- | -- |
| 11/05/2019 | Q3 | -- | $10.3B | $0.40 | -- | -- |
| 07/31/2019 | Q2 | -- | $10.1B | $0.47 | -- | -- |
| 05/14/2019 | Q1 | -- | $10.4B | $0.41 | -- | -- |
| 03/22/2019 | Q4 | -- | $8.7B | $0.41 | -- | -- |
| 11/06/2018 | Q3 | -- | $11B | $0.33 | -- | -- |
| 08/01/2018 | Q2 | -- | $10B | $0.39 | -- | -- |
| 05/08/2018 | Q1 | -- | $10.2B | $0.52 | -- | -- |
| 12/31/2017 | Q4 | -- | $10.9B | $0.60 | -- | -- |
| 11/07/2017 | Q3 | -- | $9.7B | $0.27 | -- | -- |
| 08/01/2017 | Q2 | -- | $13.8B | $1.71 | -- | -- |
| 05/05/2017 | Q1 | -- | $8.5B | $0.32 | -- | -- |
| 02/03/2017 | Q4 | -- | $8.7B | $0.30 | -- | -- |
| 11/04/2016 | Q3 | -- | $8.7B | $0.27 | -- | -- |
| 08/09/2016 | Q2 | -- | $9.7B | $0.34 | -- | -- |
| 05/06/2016 | Q1 | -- | $10.2B | $0.33 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | $0.00 | -- | -- |
Intesa Sanpaolo SpA reported $13.2B worth of top line sales in its most recent quarter.
Intesa Sanpaolo SpA announced earnings per share of $0.94 which represents a miss of analyst forecast a $0.96 per share.
Intesa Sanpaolo SpA reported -- that represents -- per share over the last quarter.
Intesa Sanpaolo SpA's earnings are forecast to grow from $3.12 per share to $2.98 per share next year representing an increase of 18.45%.
Intesa Sanpaolo SpA's next earnings date is February 3, 2026.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.